Patent · US Active

Kinase inhibitors

US8288536B2 · kind B2 · utility

14Cited by
45References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2010
Grant dateOct 16, 2012
Priority date
Expiry dateJan 8, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of:wherein the variables are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.